Diagnostic testing for coronary artery disease in a large population.

Area of Science:

• Public Health
• Health Economics
• Epidemiology

Background:

• Public health initiatives often overlook population-specific effects.
• Distinguishing between individual and population-level medical care benefits is crucial.
• Widespread screening for asymptomatic conditions carries significant cost and risk.

Purpose of the Study:

• To evaluate the cost-effectiveness and risks of large-scale diagnostic screening for coronary artery disease.
• To model the economic and health implications of population-based medical interventions.
• To demonstrate the application of integrated methods in health policy analysis.

Main Methods:

• Utilized a model integrating epidemiologic, economic, and decision analytic techniques.
• Analyzed the cost and risk ramifications of screening 20 million individuals.
• Calculated costs per person identified with disease and per survivor of surgical therapy.

Main Results:

• Screening 20 million people for coronary artery disease costs billions, with high expenditure per identified case and surgical survivor.
• The cost per year of life extended exceeds $43,000.
• Over 8,000 major complications and nearly 2,000 deaths result from screening and therapy, with half occurring in disease-free individuals.

Conclusions:

• Large-scale screening programs for coronary artery disease present substantial financial burdens and health risks to the general population.
• The model illustrates the utility of integrated methods for assessing population-based healthcare policies.
• Further research is needed to address the complexities of optimizing population-based medical care and policy decisions.